Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bonner, Alice
2014.
Dementia care in nursing homes: a golden opportunity.
International Psychogeriatrics,
Vol. 26,
Issue. 3,
p.
361.
Stephens, P.
Chikh, K.
and
Leufkens, H.
2014.
Prescribing of antipsychotics in people with dementia in acute general hospitals in England: 2010–2012.
European Geriatric Medicine,
Vol. 5,
Issue. 6,
p.
394.
Mattingly, T. Joseph
2015.
A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use.
Neurology and Therapy,
Vol. 4,
Issue. 2,
p.
169.
Lautenschlager, Nicola T.
and
Ames, David
2015.
International Psychogeriatricspaper of the year 2014: a new tradition and the first candidate for a 2024 paper of the decade?.
International Psychogeriatrics,
Vol. 27,
Issue. 4,
p.
527.
Gallagher, P.
Curtin, D.
de Siún, A.
O’Shea, E.
Kennelly, S.
O’Neill, D.
and
Timmons, S.
2016.
Antipsychotic prescription amongst hospitalized patients with dementia.
QJM,
Vol. 109,
Issue. 9,
p.
589.
Janus, Sarah I. M.
van Manen, Jeannette G.
IJzerman, Maarten J.
and
Zuidema, Sytse U.
2016.
Psychotropic drug prescriptions in Western European nursing homes.
International Psychogeriatrics,
Vol. 28,
Issue. 11,
p.
1775.
Kuronen, Marja
Kautiainen, Hannu
Karppi, Pertti
Hartikainen, Sirpa
and
Koponen, Hannu
2016.
Antipsychotic drug use and associations with neuropsychiatric symptoms in persons with impaired cognition: a cross-sectional study.
Nordic Journal of Psychiatry,
Vol. 70,
Issue. 8,
p.
621.
Anderson, Katrina
Bird, Mike
MacPherson, Sarah
and
Blair, Annaliese
2016.
How do staff influence the quality of long-term dementia care and the lives of residents? A systematic review of the evidence.
International Psychogeriatrics,
Vol. 28,
Issue. 8,
p.
1263.
Frankenthal, Dvora
Zandman-Goddard, Gisele
Ben-Muvhar, Yael
and
Porat-Katz, Bat Sheva
2016.
The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study.
Israel Journal of Health Policy Research,
Vol. 5,
Issue. 1,
Sultana, J.
Leal, I.
de Ridder, M.
Sturkenboom, M.
and
Trifiró, G.
2016.
Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study.
Epidemiology and Psychiatric Sciences,
Vol. 25,
Issue. 4,
p.
403.
Gaugler, Joseph E.
Hobday, John V.
Robbins, Joyce C.
and
Barclay, Michelle P.
2016.
Direct Care Worker Training to Respond to the Behavior of Individuals With Dementia.
Gerontology and Geriatric Medicine,
Vol. 2,
Issue. ,
Parsons, Carole
2017.
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem.
Therapeutic Advances in Drug Safety,
Vol. 8,
Issue. 1,
p.
31.
Kirkham, Julia
Sherman, Chelsea
Velkers, Clive
Maxwell, Colleen
Gill, Sudeep
Rochon, Paula
and
Seitz, Dallas
2017.
Antipsychotic Use in Dementia.
The Canadian Journal of Psychiatry,
Vol. 62,
Issue. 3,
p.
170.
Moniz-Cook, Esme
Hart, Cathryn
Woods, Bob
Whitaker, Chris
James, Ian
Russell, Ian
Edwards, Rhiannon Tudor
Hilton, Andrea
Orrell, Martin
Campion, Peter
Stokes, Graham
Jones, Robert SP
Bird, Mike
Poland, Fiona
and
Manthorpe, Jill
2017.
Challenge Demcare: management of challenging behaviour in dementia at home and in care homes – development, evaluation and implementation of an online individualised intervention for care homes; and a cohort study of specialist community mental health care for families.
Programme Grants for Applied Research,
Vol. 5,
Issue. 15,
p.
1.
Stock, Kathryn J.
Amuah, Joseph E.
Lapane, Kate L.
Hogan, David B.
and
Maxwell, Colleen J.
2017.
Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.
Drugs & Aging,
Vol. 34,
Issue. 1,
p.
39.
Donyai, Parastou
2017.
Identifying fallacious arguments in a qualitative study of antipsychotic prescribing in dementia.
International Journal of Pharmacy Practice,
Vol. 25,
Issue. 5,
p.
379.
Jokanovic, Natali
Jamsen, Kris M.
Tan, Edwin C. K.
Dooley, Michael J.
Kirkpatrick, Carl M.
and
Bell, J. Simon
2017.
Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.
Drugs - Real World Outcomes,
Vol. 4,
Issue. 4,
p.
235.
Smeets, Claudia H. W.
Gerritsen, Debby L.
Zuidema, Sytse U.
Teerenstra, Steven
van der Spek, Klaas
Smalbrugge, Martin
and
Koopmans, Raymond T. C. M.
2018.
Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors.
Aging & Mental Health,
Vol. 22,
Issue. 9,
p.
1244.
Hessmann, Philipp
Dodel, Richard
Baum, Erika
Müller, Matthias J.
Paschke, Greta
Kis, Bernhard
Zeidler, Jan
Klora, Mike
Reese, Jens-Peter
and
Balzer-Geldsetzer, Monika
2018.
Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany.
International Journal of Psychiatry in Clinical Practice,
Vol. 22,
Issue. 3,
p.
232.
Hoyle, Daniel J.
Bindoff, Ivan K.
Clinnick, Lisa M.
Peterson, Gregory M.
and
Westbury, Juanita L.
2018.
Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review.
Drugs & Aging,
Vol. 35,
Issue. 2,
p.
123.